Drug Shortage Report for VITAMIN B1
Report ID | 219763 |
Drug Identification Number | 00816078 |
Brand name | VITAMIN B1 |
Common or Proper name | VITAMIN B1 |
Company Name | SANDOZ CANADA INCORPORATED |
Market Status | MARKETED |
Active Ingredient(s) | THIAMINE HYDROCHLORIDE |
Strength(s) | 100MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAVENOUS INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR |
Packaging size | 1ML |
ATC code | A11DA |
ATC description | VIT B1,PLAIN AND IN COMB WITH VITAMIN B6 AND B12 |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | |
Actual start date | 2024-02-08 |
Estimated end date | 2024-06-03 |
Actual end date | 2024-06-17 |
Shortage status | Resolved |
Updated date | 2024-07-29 |
Company comments | Baxter item: 8400. Due to increase in market demand, Sandoz product will be available under allocation, at 200%. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 110 RUE DE LAUZON BOUCHERVILLE, QUEBEC CANADA J4B 1E6 |
Company contact information | 1 800-361-3062 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v18 | 2024-07-29 | English | Compare |
v17 | 2024-06-18 | English | Compare |
v16 | 2024-06-17 | French | Compare |
v15 | 2024-06-17 | English | Compare |
v14 | 2024-05-29 | French | Compare |
v13 | 2024-05-29 | English | Compare |
v12 | 2024-04-23 | French | Compare |
v11 | 2024-04-23 | English | Compare |
v10 | 2024-04-16 | French | Compare |
v9 | 2024-04-16 | English | Compare |
v8 | 2024-04-08 | French | Compare |
v7 | 2024-04-08 | English | Compare |
v6 | 2024-02-29 | English | Compare |
v5 | 2024-02-15 | French | Compare |
v4 | 2024-02-15 | English | Compare |
v3 | 2024-02-15 | French | Compare |
v2 | 2024-02-15 | English | Compare |
v1 | 2024-02-15 | English | Compare |
Showing 1 to 18 of 18